Intersect ENT (XENT) Tops Q3 EPS by 5c
Get Alerts XENT Hot Sheet
Join SI Premium – FREE
Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $17.84 million.
For earnings history and earnings-related data on Intersect ENT (XENT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kosmos Energy (KOS) Misses Q3 EPS by 3c
- Citi cuts TFI International price target to $123 after earnings miss
- Eastman Chemical (EMN) PT Lowered to $72 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share